87
Participants
Start Date
June 30, 2008
Primary Completion Date
May 28, 2015
Study Completion Date
May 28, 2015
natalizumab
Administered as specified in the TOUCH Prescribing Program
Research site, New York
Research site, Great Neck
Research site, Lake Success
Research site, Baltimore
Research site, Chapel Hill
Research site, Raleigh
Research site, Charlotte
Research site, Atlanta
Research site, Gainesville
Research site, Winter Park
Research site, Miami
Research site, Nashville
Research site, Louisville
Research site, Lexington
Research site, Crestview Hills
Research site, Cleveland
Research site, Cincinnati
Research site, Troy
Research site, Ann Arbor
Research site, Plymouth
Research site, Rochester
Research site, Columbia
Research site, Grapevine
Research site, Houston
Research site, Scottsdale
Research site, Oceanside
Research site, San Francisco
Research site, Tacoma
Research site, Hamden
Research site, Hartford
Research site, Boston
Research site, Boston
Research site, Lebanon
Research site, Egg Harbor
Research site, Providence
Research site, San Juan
Lead Sponsor
Biogen
INDUSTRY